The main expected benefit is a shift towards further simplification and standardization for eligible transactions. The objective of the SRT Fast-Track process is to significantly reduce the time ...
Treatment with nipocalimab led to reduced lupus disease activity in phase 2 trial. (HealthDay News) — Nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a ...
CAMBRIDGE, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...
ROCK ISLAND ARSENAL, Illinois (Sept. 9, 2025) – Army Contracting Command-Rock Island’s Source Selection Support Center of Excellence (S3COE) team, which consists of Jacob Harrison, lead procurement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results